Wakabayashi Taiga, Yagi Hiroshi, Tajima Kazuki, Kuroda Kohei, Shinoda Masahiro, Kitago Minoru, Abe Yuta, Oshima Go, Hirukawa Kazuya, Itano Osamu, Kitagawa Yuko
1 Keio University School of Medicine, Tokyo, Japan.
2 Kitasato University School of Veterinary Medicine, Aomori, Japan.
Surg Innov. 2019 Jun;26(3):312-320. doi: 10.1177/1553350619833582. Epub 2019 Mar 21.
During minimally invasive surgery, efficient and nontoxic hemostats are important for difficult to access bleeding areas. Polylactic acid is an ecofriendly hemostatic agent and we aimed to evaluate the efficacy of a polylactic acid nonwoven fabric (PLAF) developed by Toray Industries, Inc, on liver hemostasis in a preclinical study.
PLAF consists of both 1-µm diameter fibers and 100-µm diameter beaded fibers. Four rats were used, and 2 trough-shaped resections of the liver parenchyma were performed (n = 8 lobes). Immediately after the resection, PLAF (PLAF group: n = 4 lobes) or rayon gauze (Rayon group: n = 4 lobes) were applied on the resected plane and compressed manually. We compared the mean time to hemostasis and blood loss per lobe, as well as histological findings between the groups.
The PLAF group had a significantly shorter bleeding time ( P = .006), and showed lower blood loss compared with the Rayon group ( P = .076). Histopathological evaluation showed a large amount of beads on the liver surface in the PLAF group. Aggregated red blood cells evident by electron microscopy and von Willebrand factor immunofluorescence were seen surrounding the beads. The PLAF group showed significantly greater von Willebrand factor expression than the Rayon group ( P = .004).
This new PLAF showed superior outcomes thanks to its unique characteristic of forming beaded nanofibers, and it has the potential to be an efficient hemostat in minimally invasive surgery in the human body.
在微创手术中,高效且无毒的止血剂对于难以触及的出血区域至关重要。聚乳酸是一种环保型止血剂,我们旨在通过一项临床前研究评估东丽工业株式会社研发的聚乳酸无纺布(PLAF)对肝脏止血的疗效。
PLAF由直径1μm的纤维和直径100μm的珠状纤维组成。使用4只大鼠,对肝脏实质进行2次槽形切除(n = 8个叶)。切除后立即将PLAF(PLAF组:n = 4个叶)或人造丝纱布(人造丝组:n = 4个叶)应用于切除平面并手动按压。我们比较了每组每叶的平均止血时间和失血量,以及组织学结果。
PLAF组的出血时间明显更短(P = .006),与人造丝组相比失血量更低(P = .076)。组织病理学评估显示PLAF组肝脏表面有大量珠子。通过电子显微镜和血管性血友病因子免疫荧光可见聚集的红细胞围绕在珠子周围。PLAF组显示出比人造丝组明显更高的血管性血友病因子表达(P = .004)。
这种新型PLAF因其形成珠状纳米纤维的独特特性而显示出优异的效果,并且有潜力成为人体微创手术中的一种高效止血剂。